Aribulin Combined With Carboplatin and Bevacizumab in the Treatment of Ovarian Cancer

NCT05965141 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Aribulin;carboplatin;bevacizumab

Sponsor

Second Affiliated Hospital of Guangzhou Medical University